Search - tctmd.com

Displaying 581 - 600 of 752

Sort: Relevancy | Date

News Daily News

El Dabigatran Reduce los ACV Hemorrágicos en Pacientes con FA de Cualquier Grupo Étnico

June 26, 2013

News Daily News

Dabigatran Reduces Hemorrhagic Stroke in A-fib Patients Across Ethnic Groups

June 26, 2013

Presentation

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Presenter: M. Hori

June 21, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

ROCKET AF: La Insuficiencia Cardíaca No Resta Validez del Rivaroxaban

Caitlin E. Cox

June 20, 2013

News Daily News

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Caitlin E. Cox

June 20, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Presenter: Michael Ezekowitz

June 15, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

Advertisement

El Dabigatran Reduce los ACV Hemorrágicos en Pacientes con FA de Cualquier Grupo Étnico

Dabigatran Reduces Hemorrhagic Stroke in A-fib Patients Across Ethnic Groups

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

ROCKET AF: La Insuficiencia Cardíaca No Resta Validez del Rivaroxaban

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content